Nanjing Zhongke Biochemical Technology Co. Ltd. – Trademark Portfolio

Entity Type: 16

Nanjing Zhongke Biochemical Technology Co. Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include SINO-SCI and ZK ZHONGKE. The owner is based in Nanjing.

73# East Beijing Road

Nanjing 210008 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Nanjing Zhongke Biochemical Technology Co. Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Nanjing Zhongke Biochemical Technology Co. Ltd. have?

Nanjing Zhongke Biochemical Technology Co. Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Nanjing Zhongke Biochemical Technology Co. Ltd. file in?

Nanjing Zhongke Biochemical Technology Co. Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Nanjing Zhongke Biochemical Technology Co. Ltd.'s most well-known trademarks?

Nanjing Zhongke Biochemical Technology Co. Ltd.'s registered trademark portfolio includes well-known marks such as SINO-SCI and ZK ZHONGKE. These are among 2 currently registered trademarks in the portfolio.

What is Nanjing Zhongke Biochemical Technology Co. Ltd.'s trademark registration success rate?

Nanjing Zhongke Biochemical Technology Co. Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.